Breast cancer targeted chemotherapy based on doxorubicin-loaded bombesin peptide modified nanocarriers

Abstract

The results demonstrated that Bn-DOX/SLNs reversed the resistance of doxorubicin, suggesting that chemotherapy using this kind of targeted nanocarriers may benefit human breast MDR cancer therapy.